Back
TG Therapeutics, Inc. 10K Form
Sell
39
TGTX
TG Therapeutics, Inc.
Last Price:
$31.37
Seasonality Move:
25.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TGTX News And Ratings
See the #1 stock for the next 7 days that we like better than TGTX
TGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $329M |
|---|---|
| Cash Flow: | $-23.2M |
| Price / Cash Flow: | 53.48 |
| Annual Sales: | $3.91 |
| Price / Book: | 8.26 |
Profitability
| EPS (TTM): | 2.77810 |
|---|---|
| Net Income (TTM): | $447.5M |
| Gross Margin: | $290.2M |
| Return on Equity: | 145.71% |
| Return on Assets: | 63.06% |
TG Therapeutics, Inc. Earnings Forecast
Key TG Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for TGTX is 88.22%.
-
The Selling, General & Administrative Expenses for TGTX have been equal to 46.90% of Gross Profit Margin.
-
The Research & Development expenses have been 28.66% of Revenue.
-
The Interest Expense is 102.76% of Operating Income.
-
The Net Earning history of TGTX is 7.11% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
TG Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TGTX |
| CUSIP: | 88322Q |
| Website: | tgtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 3.82 |
| Quick Ratio: | 2.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 216.8 |
|---|---|
| Forward P/E Ratio: | 16.41 |
TGTX Technical Analysis vs Fundamental Analysis
Sell
39
TG Therapeutics, Inc. (TGTX)
is a Sell
Is TG Therapeutics, Inc. a Buy or a Sell?
-
TG Therapeutics, Inc. stock is rated a SellThe current TG Therapeutics, Inc. [TGTX] share price is $31.61. The Score for TGTX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.